- Rising demand for PCR-based respiratory panels stimulating growth in Europe and Middle East & Africa respiratory panel testing market
- Europe emerged as most lucrative market in 2020 because of rising prevalence of respiratory diseases and increasing geriatric population in countries such as Germany and the U.K.
WILMINGTON, Del., Oct. 24, 2022 /PRNewswire/ -- The last few years have witnessed increase in patient population suffering from respiratory diseases in countries in Europe and Middle East and Africa regions. As a result, demand for respiratory panels to test patients has risen which has helped in market growth.
The Europe and Middle East & Africa respiratory panel testing market is projected to advance at CAGR of 5.1% during the forecast period, starting in 2022 and ending in 2031.
Prominent market players are looking to generate new revenue streams and gain a competitive edge over other market players by launching new products.
Get Exclusive PDF Sample Copy of Europe and Middle East & Africa Respiratory Panel Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84240
Well-established market players are also looking to expand their presence in global market and increase their revenue, by signing collaborative agreements.
Key Findings of Europe and Middle East & Africa Respiratory Panel Testing Market Study
- Increasing Demand for PCR-based Respiratory Panels Triggering Growth in Europe and Middle East & Africa Respiratory Panel Testing Market: The last few years have witnessed an increase in demand for PCR-based panels to identify pathogens. Furthermore, PCR-based panels are emerging as suitable alternative to viral culture to identify viral nucleic acids and offer results with improved specificity and sensitivity. Leading manufacturers are increasing the production of multiplex PCR-based virus panels to test patients suffering from influenza, rhinovirus, and respiratory syncytial virus.
- Rising Demand for Syndromic Full Multiplex Panels Boosting Market Growth: Syndromic full multiplex panel type segment held a major share in Europe and Middle East & Africa respiratory panel testing market, in 2020. Rising use in identification of multiple target pathogenic DNA or RNA, as well as increased deployment in clinical care emerged as key factors, driving the growth in the segment and contributed to respiratory panel testing market growth in Europe and Middle East & Africa
- Increasing Hospital Admissions Could Augment Growth in Europe and Middle East & Africa Respiratory Panel Testing Market: Hospital end-use segment is expected to hold a major share in the Europe and Middle East & Africa respiratory panel testing market, during the forecast period. Rising prevalence of respiratory diseases is expected to lead to increase in hospital admissions, which could fuel the demand for respiratory panel testing and boost the market growth
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84240
Europe and Middle East & Africa Respiratory Panel Testing Market: Key Drivers
- Increasing prevalence of respiratory tract infections is one of the key growth drivers of Europe and Middle East & Africa respiratory panel testing market
- Rising prevalence of hospital-acquired infections is expected to fuel the demand for respiratory panel testing and trigger the market growth in europe and middle east and africa
Europe and Middle East & Africa Respiratory Panel Testing Market: Regional Market Insights
- Europe emerged as the dominant region in global market in 2020. Increase in prevalence of respiratory disorders and rising geriatric population in countries such as the U.K. and Germany played key roles in the region emerging as the leader in overall market
- Germany is anticipated to emerge as the leading country in the market in Europe during the forecast period because of presence of well-established medical diagnostics industry, as well as outbreak of COVID-19 pandemic in the country, leading to increase in demand for respiratory testing panels
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84240
Europe and Middle East & Africa Respiratory Panel Testing Market: Key Players
Competition landscape in Europe and Middle East & Africa respiratory panel testing market is fragmented, owing to the presence of numerous well-established market players.
Few leading players include Dickinson and Co., Becton, Medline Industries, QIAGEN, and Anatolia Geneworks.
Europe and Middle East & Africa respiratory panel testing market is segmented as follows:
- By Specimen Type
- Viruses
- Adenovirus
- Severe Acute Respiratory Syndrome Coronavirus 2
- RSV
- Human Metapneumovirus
- Rhinovirus/Enterovirus
- Parainfluenza Virus
- Flu A
- Coronavirus
- Flu B
- H1N12009
- Others
- Bacteria
- Mycoplasma Pneumoniae
- Chlamydophila Pneumonia
- Bordetella Pertussis
- Bordetella Parapertussis
- By Panel Type
- Syndromic Full Multiplex Panel
- Low Flex Panel
- By End-use
- Hospital Point-of-Care Testing
- Ref Laboratories
- Hospitals
- Others
- Regions Covered
- Europe
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Cancer Diagnostics Market: The global cancer diagnostics market is anticipated to reach more than US$ 335.7 Bn by the end of 2031 at a CAGR of 7.4% from 2022 to 2031.
Non-invasive Prenatal Testing Market: The global non-invasive prenatal testing market is anticipated to reach more than US$ 8.4 Bn by the end of 2031 at a CAGR of 14.8% from 2022 to 2031.
Diagnostic Imaging Services Market: The global diagnostic imaging services market is anticipated to be valued more than US$ 544.7 Bn by the end of 2031 at a CAGR of 4.1% from 2022 to 2031.
Diagnostic Reagents Market: The global diagnostic reagents market is anticipated to reach more than US$ 85.8 Bn by the end of 2031 at a CAGR of 6.5% from 2022 to 2031.
Cervical Cancer Diagnostic Tests Market: The global cervical cancer diagnostic tests market is expected to exceed value of US$ 13.6 Bn by the end of 2031 at a CAGR of 4.6% from 2022 to 2031.
Central Lab Market: The global central lab market is expected to reach the value of US$ 4 Bn by the end of 2031 at a CAGR of 5.4% from 2021 to 2031.
In Vitro Diagnostics Market: The global in vitro diagnostics market is expected to reach the value of US$ 115.43 Bn by the end of 2028 at a CAGR of 6.3% from 2021 to 2028.
Companion Diagnostics Market: The global companion diagnostics market is expected to reach the value of US$ 9.30 Bn by the end of 2028 at a CAGR of 9% from 2021 to 2028.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
Share this article